1. Home
  2. WLK vs RDY Comparison

WLK vs RDY Comparison

Compare WLK & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLK
  • RDY
  • Stock Information
  • Founded
  • WLK 1986
  • RDY 1984
  • Country
  • WLK United States
  • RDY India
  • Employees
  • WLK N/A
  • RDY N/A
  • Industry
  • WLK Major Chemicals
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLK Industrials
  • RDY Health Care
  • Exchange
  • WLK Nasdaq
  • RDY Nasdaq
  • Market Cap
  • WLK 10.1B
  • RDY 11.6B
  • IPO Year
  • WLK 2004
  • RDY N/A
  • Fundamental
  • Price
  • WLK $58.61
  • RDY $14.01
  • Analyst Decision
  • WLK Buy
  • RDY Strong Buy
  • Analyst Count
  • WLK 15
  • RDY 1
  • Target Price
  • WLK $88.87
  • RDY $16.90
  • AVG Volume (30 Days)
  • WLK 1.3M
  • RDY 1.2M
  • Earning Date
  • WLK 10-30-2025
  • RDY 10-24-2025
  • Dividend Yield
  • WLK 3.62%
  • RDY 0.51%
  • EPS Growth
  • WLK N/A
  • RDY 9.95
  • EPS
  • WLK N/A
  • RDY 0.79
  • Revenue
  • WLK $11,480,000,000.00
  • RDY $3,851,623,984.00
  • Revenue This Year
  • WLK N/A
  • RDY $6.29
  • Revenue Next Year
  • WLK $3.14
  • RDY $2.61
  • P/E Ratio
  • WLK N/A
  • RDY $17.72
  • Revenue Growth
  • WLK N/A
  • RDY 14.10
  • 52 Week Low
  • WLK $57.43
  • RDY $12.26
  • 52 Week High
  • WLK $133.51
  • RDY $16.17
  • Technical
  • Relative Strength Index (RSI)
  • WLK 24.75
  • RDY 52.49
  • Support Level
  • WLK $62.30
  • RDY $13.71
  • Resistance Level
  • WLK $65.68
  • RDY $14.05
  • Average True Range (ATR)
  • WLK 2.68
  • RDY 0.18
  • MACD
  • WLK -0.61
  • RDY 0.06
  • Stochastic Oscillator
  • WLK 8.38
  • RDY 95.86

About WLK Westlake Corporation

Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: